FIELD: medicine.
SUBSTANCE: invention refers to medicine and biology, particularly concerns hepatocyte regeneration stimulation. For this purpose, under experimental conditions animal is subcutaneously or intramuscularly administered with porous graft in form of calcium phosphate matrix with pore diameter in range of 150-600 mqm, or in form of said matrix with pre-applied syngeneic bone marrow.
EFFECT: method provides high regenerative potential of endogenic hepatocytes throughout long period with lower risk of potential complications and reduction of costs.
1 cl, 2 ex, 2 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425648C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425645C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425647C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425646C1 |
METHOD OF TREATING HEPATIC FAILURE | 2017 |
|
RU2655528C1 |
USE OF TOTAL RIBONUCLEIC ACID (RNA) FROM MULTIPOTENT MESENCHYMAL STROMAL CELLS OF THE MAMMAL'S BONE MARROW AS METHOD FOR CORRECTING LIVER FAILURE | 2017 |
|
RU2655761C1 |
METHOD OF CORRECTION OF HEPATIC INSUFFICIENCY IN THE EXPERIMENT | 2017 |
|
RU2650209C1 |
METHOD OF TREATING HEPATIC FAILURE | 2015 |
|
RU2586952C1 |
TREATMENT METHOD OF LIVE FAILURE | 2016 |
|
RU2618989C1 |
BIOTRANSPLANT, TREATMENT METHOD OF CHRONIC LIVER DISEASES AND TREATMENT METHOD OF LIVER CIRRHOSIS AND PORTAL HYPERTENSION | 2007 |
|
RU2368384C2 |
Authors
Dates
2016-07-10—Published
2015-06-30—Filed